Belgium Antimicrobial Susceptibilty Testing Market to 2032
Overview
The Belgium Antimicrobial Susceptibilty Testing Market is expected to reach a 42.60 USD Million by 2032 and is projected to grow at a CAGR of 4.76% from 2025 to 2032.
Belgium Antimicrobial Susceptibilty Testing Market 2018-2032 USD Million
Belgium Antimicrobial Susceptibilty Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 33.34 USD Million
- Projected Market Size (2032): 42.60 USD Million
- CAGR (2025-2032): 4.76%
Key Findings of Belgium Antimicrobial Susceptibilty Testing Market
- The Belgium Antimicrobial Susceptibilty Testing Market was valued at 33.34 USD Million in 2024.
- The Belgium Antimicrobial Susceptibilty Testing Market is likely to grow at a CAGR of 4.76% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Sales in Distribution Channel Segment accounted for the largest share of the market with a revenue of 25.68 USD Million
- The fastest growing segment E-Test in Method Segment grew Fastest with a CAGR of 6.41% during the forecast period from 2024 to 2032.
Belgium Antimicrobial Susceptibilty Testing Market Scope
- Others
- Geneotypic Methods
- E-Test
- Mass Spectrometry Method
- Dilution
- Disk Diffusion
- Service & Software
- Consumables & Accessories
- Instruments
- Third Party Distributor
- Retail Sales
- Direct Sales
- Others
- Research Centres and Academic Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology companies
- Diagnostic Laboratories
- Hospitals
- Others
- Epidemiology
- Drug Discovery and Development
- Clinical Diagnostics
- Others
- Anti Fungal Testing
- Anti Bacterial Testing
Belgium Antimicrobial Susceptibilty Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 33.34 USD Million |
| Market Value in 2032 | 42.60 USD Million |
| CAGR (2025-2032) | 4.76% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Method,Product Type,Distribution Channel,End User,Application,Type |
Regional Insights:
-
Leading Market (2024-2032): Belgium, leading in terms of revenue 33.34 USD Million in 2024
- Key Country: Belgium, leading in terms of revenue with value of 33.34 USD Million in 2024.
Segments and Scope
-
Belgium Antimicrobial Susceptibilty Testing Market to 2032, By Method
- Disk Diffusion is the largest segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 17.59 USD Million in the year 2024.
- E-Test is the Fastest growing segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 6.01 % in forecast period 2025-2032.
-
Belgium Antimicrobial Susceptibilty Testing Market to 2032, By Product Type
- Instruments is the largest segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 20.50 USD Million in the year 2024.
- Instruments is the Fastest growing segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 5.49 % in forecast period 2025-2032.
-
Belgium Antimicrobial Susceptibilty Testing Market to 2032, By Distribution Channel
- Direct Sales is the largest segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 25.68 USD Million in the year 2024.
- Direct Sales is the Fastest growing segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 5.19 % in forecast period 2025-2032.
-
Belgium Antimicrobial Susceptibilty Testing Market to 2032, By End User
- Hospitals is the largest segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 19.84 USD Million in the year 2024.
- Diagnostic Laboratories is the Fastest growing segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 4.85 % in forecast period 2025-2032.
-
Belgium Antimicrobial Susceptibilty Testing Market to 2032, By Application
- Clinical Diagnostics is the largest segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 24.70 USD Million in the year 2024.
- Clinical Diagnostics is the Fastest growing segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 5.21 % in forecast period 2025-2032.
-
Belgium Antimicrobial Susceptibilty Testing Market to 2032, By Type
- Anti Bacterial Testing is the largest segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 25.45 USD Million in the year 2024.
- Anti Bacterial Testing is the Fastest growing segment in Belgium Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 5.13 % in forecast period 2025-2032.
Belgium Antimicrobial Susceptibilty Testing Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Mast Group Ltd. | |||
| Liofilchem S.r.l. | |||
| Thermo Fisher Scientific Inc. | |||
| Rosco Diagnostica A/S | |||
Belgium Antimicrobial Susceptibilty Testing Market Geographical Sales Distribution, 2018-2032 USD Million
Belgium Antimicrobial Susceptibilty Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Coming Soon....
Belgium Antimicrobial Susceptibilty Testing Market Scope
- Others
- Geneotypic Methods
- E-Test
- Mass Spectrometry Method
- Dilution
- Disk Diffusion
- Service & Software
- Consumables & Accessories
- Instruments
- Third Party Distributor
- Retail Sales
- Direct Sales
- Others
- Research Centres and Academic Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology companies
- Diagnostic Laboratories
- Hospitals
- Others
- Epidemiology
- Drug Discovery and Development
- Clinical Diagnostics
- Others
- Anti Fungal Testing
- Anti Bacterial Testing
Frequently Asked Questions
Belgium Antimicrobial Susceptibilty Testing Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.